The Effects of NF-kappa B Signalling on the TNF-alpha-induced Ratios of MMPs to TIMPs in Chondrocytes
Abstract
To explore the influence of the NF-κB inhibitor (bay11-7082) on tumor necrosis factor-alpha (TNF-α)-induced different ratios of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in chondrocytes. Methods Chondrocytes were isolated from the knee joint of a 1-day old mouse by trypsin digestion method. Hematoxylin-Eosin (HE) stain was used to show the morphology of isolated chondrocytes; Semi-quantitative PCR was applied to analyze the influence of bay11-7082 on gene expressions of TNF-α-induced MMPsand TIMPsin chondrocytes; Zymography was used to elucidate activities of the gelatinases induced by TNF-α and/or bay11-7082. Results TNF-α up-regulated gene expressiosn of the MMPsand TIMPs(P<0.05). The ratios of MMPs/TIMPswere mostly increased except the part of MMP-1. Bay11-7082 could reduce TNF-α-induced MMPsand TIMPsgene expressions, and could make the increased ratio of MMPs/TIMPsdropped to the normal level of chondrocytes. Similar results were observed at the protein level of the gelatinases by zymography. Conclusion TNF-α-induced high ratios of MMPs/TIMPs could partiallyexplain over-degradation of cartilage extracellular matrix in osteoarthritis (OA). Blockage of NF-κB with bay11-7082 might provide a possible therapeutic strategy for the OA deterioration.
Keywords: Chondrocyte, TNF-α NF-κB, MMPs, TIMPs
Full Text:
PDFReferences
LE LT.SWINGLER ТЕ. CLARK IM. Review: the role of microRNAs in osteoarthritis and chondrogenesis. Arthritis Rheum,2013,65(8): 1963-1974.
NESIC D,WHITESIDE R. BRITT BERG M ,et al. Cartilage tissue engineering for degenerative joint disease. Adv Drug Deliver Rev, 2006,58( 2): 300-322.
MONACH PA, WARNER RL, TOMASSON GPA, et al. Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis. Ann Rheum Dis,2013,72(8): 1342-1350.
CARMELI E, MOAS M, REZNICK AZ, et al. Matrix metalloproteinases and skeletal muscle;a brief review. Muscle Nerve, 2004,29(2): 191-197.
AL-HIZAB F, CLEGG PD, THOMPSON CC, et al. Microscopic localization of active gelatinases in equine osteochondritis dissecans ( OCD ) cartilage. Osteoarthr Cartilage,2002,10(8): 653-661.
HUANG WS.LI WQ.DEHNADE F, et al. Tissue inhibitor of metalloproteinases-4 ( TIMP-4 ) gene expression is increased in human osteoarthritic femoral head cartilage. J Cell Biochem,2002,85(2) :295-303.
WANG JJ.HUAN SK.HSIEH KH, et al. Inhibitory effect of midazolam on MMP-9, MMP-1 and MMP-13 expression in PMA-stimulated human chondrocytes via recovery of NF- kappaB signaling. Arch Med Sci,2013,9(2) ;332-339. MARTEL-PELLETIER J, PELLETIER JP. New insights into the major pathophysiological processes responsible for the development of osteoarthritis. Semin Arthritis Rheum, 2005,34(6 Suppl 2):6-8.
FRANK S,PETERS MA, WEHMEYER C.et al. Regulation of matrixmetalloproteinase-3 and matrixmetalloproteinase-13 by SUMO-2/3 through the transcription factor NF-kappaB. Ann Rheum Dis,2013,72( 11): 1874-1881.
XIE J, WANG C, YIN L, et al. Interleukin-1 beta influences on lysyl oxidases and matrix metalloproteinases profile of injured anterior cruciate ligament and medial collateral ligament fibroblasts. Int Orthop.2013,37(3) ;495-505.
BLAIN EJ,GILBERT SJ , HAYES AJ ,et al. Disassembly of the vimentin cytoskeleton disrupts articular cartilage chondrocyte homeostasis. Matrix Biol,2006,25(7) :398-408.
KIM HA.CHO ML,CHOI HY. Et al The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum,2006,54(7):2152-2163.
KIM JH.HUH JE.BAEK YH.et al. Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes. J Ethnopharmacol.2011,134(2);234-242.
XIE J.JIANG J.ZHANG Y, el at. Up-regulation expressions of lysyl oxidase family in Anterior Cruciate Ligament and Medial Collateral Ligament fibroblasts induced by Transforming Growth Factor-Beta 1. Int Orthop, 2012, 36 (1): 207-213.
ADAMS SB, SETTON LA, BELL RD. et al. Inflammatory Cytokines and Matrix Metalloproteinases in the Synovial Fluid After Intra-articular Ankle Fracture. Foot Ankle Int, 2015,36(11);1264-1271.
JALBA BA,JALBA CS, VLADOI AD, et al. Alterations in expression of cartilage-specific genes for aggrecan and collagen type II in osteoarthritis. Rom J Morphol Embryol, 2011.52(2)t587-591.
KOSKINEN A, VUOLTEENAHO K. NIEMINEN R.et al. Leptin enhances MMP-1. MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients. Clin Exp Rheumatol,2011 ,29( 1);57-64.
RUBENHAGEN R.SCHUTTRUMPF JP.STURMER KM. et al. Interleukin-7 levels in synovial fluid increase with age and MMP-1 levels decrease with progression of osteoarthritis. Acta Orthop,2012,83( 1);59-64.
RAYMOND L.ECK S, MOLLMARK J .et al. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta. J Cell Physiol, 2006, 207 (3); 683-688.
MENGSHOL J A, VINCENTI MP, COON Cl, et al. Interleukin-1 induction of collagenase 3 ( matrix metalloproteinase 13 ) gene expression in chondrocytes requires p38. c-Jun N-terminal kinase, and nuclear factor kappaB; differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum.2000.43(4):801-811.
RANNOU FO, FRANCOIS M, CORVOL MT, et al. Cartilage breakdown in rheumatoid arthritis. Joint Bone Spine,2006,73(1): 29-36.
ELLIOTT SF, COON Cl, HAYS E, et al. Bcl-3 is an interleukin-1-responsive gene in chondrocytes and synovial fibroblasts that activates transcription of the matrix metalloproteinase 1 gene. Arthritis Rheum. 2002. 46 ( 12 ): 3230-3239.
TANG ZY, YANG L.XUE RY,et al. Differential expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in anterior cruciate ligament and medial collateral ligament fibroblasts after a mechanical injury; involvement of the p65 subunit of NF-kB. Wound Repair Regen,2009,17(5):709-716.
Refbacks
- There are currently no refbacks.



